1.Factors related to severe acute radiation-induced lung injury caused by IMRT for non-small cell lung cancer
Bo YAN ; Qingsong PANG ; Yulong CHEN ; Zhiyong YUAN ; Ying TANG
Chinese Journal of Clinical Oncology 2016;(3):116-119
Objective:To study the related factors of severe acute radiation-induced lung injury (SAR) caused by IMRT and concurrent chemotherapy for non-small cell lung cancer. Methods:We retrospectively analyzed the data of 2 323 non-small cell lung cancer pa-tients who underwent IMRT radiotherapy and concurrent chemotherapy at the Department of Radiotherapy of Tianjin Medical Univer-sity Cancer Institute and Hospital from January 2010 to January 2014. We analyzed the clinical factors and parameters that affect dose by univariate and multivariate analysis. Results:A total of 2 323 patients enrolled and 1 241 cases suffering from acute radiation-in-duced lung injury with the rate of 53.4%. Only 185 cases suffered from SARP with a rate of 7.96%. Univariate analysis showed that the gender, histopathological type, total radiation dose, V5 (%), and average dose rate are not related to SARP (P>0.05). By contrast an age of>60 years, 1%predicted FEV, docetaxel+carboplatin/cisplatin chemotherapy, V20 (%), V30 (%), and mean lung dose (MLD) are sig-nificantly related to SARP (P<0.05). Multivariate analysis showed that a patient age of>60 years, docetaxel+carboplatin/cisplatin che-motherapy, V20 (%), and V30 (%) are the independent risk factors of SARP. Conclusion:Among the non-small cell lung cancer patients undergoing IMRT radiotherapy and concurrent chemotherapy, further attention should be given to elderly patients, patients receiving docetaxel and platinum chemotherapy, as well as V20 and V30 with high doses. The necessary preventive treatment should be given to reduce the incidence of SARP, improve the quality of life of patients, and reduce the incidence of respiratory failure and mortality.
2.Application and mechanism of nanomedicine and nanomaterials in antibacterial infection therapy
Ying-ying HE ; Wen-bo ZHOU ; Qi-wei TAI ; Rong-jie LI ; Yuan YU
Acta Pharmaceutica Sinica 2023;58(1):106-117
Antibacterial therapy is a global health issue. The antibiotic resistance is becoming an increasingly serious threat, which caused by misuse and overuse of antibacterial agents combined with the emergence of new resistance mechanism. The resulting infection treatment risk and incidence of the spread of disease, severe cases and deaths are increased in different degrees. With the extensive application of biomaterials and nanotechnology to biomedicine, extensive research has been conducted on antibacterial infection. With the specific physicochemical properties like optical, electric and magnetic and high penetration, inorganic nanomaterials can produce natural antibacterial effect. Nanomedicine can be designed to allow controlled drug release and targeting effect, thus demonstrated better antibacterial efficiency. In this review, the mechanism of antibacterial resistance is described, and the antibacterial infection research on inorganic nanomaterials, as well as nano-drug delivery system including liposomes, nanoparticles, dendrimers and biomimetic nanocarriers are summarized. Nanomaterials and nanotechnology offer promising strategies for the development of new agents that can improve efficacy on antibacterial infections and overcome antibiotic resistance potentially.
3.Advance in Quantitative Tests of Muscle Strength Measurement (review)
Genlin LIU ; Jianjun LI ; Hongjun ZHOU ; Haiqiong KANG ; Ying ZHENG ; Chunxia HAO ; Ying ZHANG ; Bo WEI ; Xiaolei LU ; Yuan YUAN
Chinese Journal of Rehabilitation Theory and Practice 2017;23(7):766-769
As the manual muscle testing is not sensitive enough to reflect the change of muscle strength, more and more people begin to use isokinetic dynamometry and handheld dynamometer for quantitative tests of muscle strength measurement. This paper briefly introduced the history of clinical approaches of muscle strength measurement, compared the advantages and disadvantages of various quantitative mus-cle strength testing, on which the specific techniques of clinical muscle strength measurement were discussed.
4.Retrospective Analysis of Thromboembolism Prophylaxis in 115 Patients with Spinal Cord Injury
Bo WEI ; Hongjun ZHOU ; Genlin LIU ; Yiji WANG ; Ying ZHENG ; Ying ZHANG ; Chunxia HAO ; Haiqiong KANG ; Xiaolei LU ; Yuan YUAN
Chinese Journal of Rehabilitation Theory and Practice 2016;22(8):936-941
Objective To retrospectively analyze the lower extremity deep vein thrombosis prevention in patients with spinal cord injury (SCI). Methods A total of 115 SCI patients in our department from April to May, 2015 were included. The clinical symptoms, lower limb deep vein ultrasonic testing, laboratory examination were collected to analyze the occurrence, prevention measures, the thrombus location and management of deep venous thrombosis (DVT) in lower limbs. Results Forty-three patients had thromboprophylaxis in other hospitals before admission, and 105 patients in our department after admission, in which, nine cases were with clinical symptoms in other hospitals and three cases in our department. No pulmonary embolism occurred in them. There was no significant difference in most laboratory index-es between patients with DVT and without DVT in lower limbs (P>0.05). Five patients were with DVT in lower limbs in 43 patients who had thromboprophylaxis, and four cases in 72 patients who did not have thromboprophylaxis. No relationship was found between thrombo-prophylaxis and DVT in lower limbs (χ2=0.663, P=0.415). Five patients were with DVT in lower limbs in 53 patients with complete SCI, and four cases in 59 patients with incomplete SCI. No relationship was found between the severity of SCI and DVT in lower limbs in other hospitals (χ2=0.028, P=0.867). Conclusion DVT in lower limbs could be also occurred in patients who accepted thromboprophylaxis. Labo-ratory indexes are inadequate for the prediction and diagnosis specificity of DVT in lower limbs.
5.International Spinal Cord Injury: Spinal Interventions and Surgical Procedures Basic Data Set MF Dvorak, E Itshayek, MG Felings, AR Vaccaro, PC Wing, F Biering-Sorensen, VK Noonan
Haiqiong KANG ; Hongjun ZHOU ; Genlin LIU ; Ying ZHENG ; Ying ZHANG ; Chunxia HAO ; Bo WEI ; Yiji WANG ; Xiaolei LU ; Yuan YUAN
Chinese Journal of Rehabilitation Theory and Practice 2015;21(8):869-878
Study design Survey of expert opinion, feedback and final consensus. Objective To describe the development and the variables included in the International Spinal Cord Injury (SCI) Spinal Interventions and Surgical Procedures Basic Data set. Setting International working group. Methods A committee of experts was established to select and define data elements. The data set was then disseminated to the appropriate committees and organizations for comments. All suggested revisions were considered and both the International Spinal Cord Society and the American Spinal Injury Association endorsed the final version. Results The data set consists of nine variables: (1) Intervention/ Procedure Date and start time (2) Non-surgical bed rest and external immobilization, (3) Spinal intervention-closed manipulation and/or reduction of spinal elements, (4) Surgical procedure-approach, (5) Date and time of the completion of the intervention or surgical closure; (6) Surgical procedure-open reduction, (7) Surgical procedure-direct decompression of neural elements, and (8 and 9) Surgical procedure- stabilization and fusion (spinal segment number and level). All variables are coded using numbers or characters. Each spinal intervention and procedure is coded (variables 1 through 7) and the spinal segment level is described (variables 8 and 9). Sample clinical cases were developed to illustrate how to complete it. Conclusion The International SCI Spinal Interventions and Surgical Procedures Basic Data Set was developed to facilitate comparisons of spinal interventions and surgical procedures among studies, centers and countries.
6.Variation of Blood Pressure and Heart Rate after Cervical Spinal Cord Injury (review)
Xiaolei LU ; Hongjun ZHOU ; Genlin LIU ; Ying ZHENG ; Chunxia HAO ; Ying ZHANG ; Haiqiong KANG ; Bo WEI ; Yijie WANG ; Yuan YUAN
Chinese Journal of Rehabilitation Theory and Practice 2014;(2):153-155
There is autonomic nerve dysfunction after cervical spinal cord injury. Fluctuation of blood pressure and heart rate was found as orthostatic hypotension and bradycardia.
7.Cloning and expression of human filaggrin gene and detection of anti-filaggrin antibodies for diagnosis of rheumatoid arthritis
Bo SHEN ; Wei XU ; Jun LI ; Xiaoxue ZHANG ; Zhaolin YUAN ; Ying FU ; Min ZHU ; Zhefeng MENG
Chinese Journal of Laboratory Medicine 2010;33(2):121-125
Objective To construct the recombinant plasmid containing human filaggrin gene,purify and identify the immunoreactivity of the recombinant protein,and establish the indirect ELISA to detect AFA for diagnosis of RA.Methods The constructed plasmids were transformed into E. Coli Rosettagami(DE3).This fusion protein was purified by NAT chromatography.ELISA coated with the fusion protein Was established to detect the AFA in serum of patients,which included 114 cases of RA,56 cases of SLE,32 cases of OA and 40 cases of normal controls. The correlation between the results of AFA and anti-CCP in RA group were compared. Results 321 bp fragment of filaggrin gene was amplified and the recombinant expression vector pET-28a( + )-filaggrin was constructed. The sequence of filaggrin gene was the same as the sequence reported in the literatures. The Rosetta-gami (DE3) strains of E. Coli with recombinant vector showed high level of filaggrin protein after induction. The SDS-PAGE showed that the plasmid expressed the filaggrin fusion protein with molecule weight of 14 000 Da. The expression protein could be purified by Ni-NAT with activity. The absorbance value of AFA in RA group was 0.473 ±0. 248 while they were 0. 160 0. 088, 0. 121±0. 070, 0.050 0. ±018 in SLE, OA and normal groups respectively. There were significant differences of absorbance values of AFA between RA and SLE, OA, control group (t = 12.004, 14. 464, 18.078, P<0. 01, respectively). The positivities of anti-filaggrin in RA, SLE and OA were 48.2%, 5.4% and 3. 1% respectively. The positivities of AFA were significantly different between RA, OA and normal control groups (x~2 = 67. 088, P < 0. 01). There was positive correlation of results between AFA and anti-CCP antibody (r = 0.42, P < 0. 05 ) . The consistency rate of results between AFA and anti-CCP was 70. 1%. Anti-CCP was negative in 10 out of 114 patients with AFA positive. AFA can be used to diagnose RA with sensitivity of 48. 2% , specificity of 96.9% , positive predictive value of 93. 2% and negative predictive values of 67. 9% . Conclusions The purified human filaggrin fusion protein is successfully purified. The indirect ELISA method based on the recombinant protein shows good sensitivity and specificity. Joint detection with AFA and anti-CCP can improve the positive rate of detection.
8.Changes of Nitric Oxide and Circulating Endcthelial Cells in Children with Acute Lower Respiratory Tract Infection
hua-qiang, LI ; yuan, SHI ; su-zeng, FENG ; jie, PAN ; ying-bo, YANG ; ji-gao, SHEN
Journal of Applied Clinical Pediatrics 1986;0(02):-
Objectives To search for the pathogenesis of vaseular endothelial injury and its clinical significance.Methods 36 patients with acute lower respiratory trect infection(ALRI)and 30 healthy controls were envolved. Circulating endothelial cells (CEC)and nitric oxide (NO) levels were tested.Results Circulating nitrite/nitra levels,the stable metabolic products of NO,were found to be significantly higher in the patients with ALRI (44.6?22.6umol/L) than that in the controls (24.5?14.1umoI /L, P
9.The mechanism of alteronol inhibiting the proliferation of human promyelocytic leukemia HL-60 cells.
Liangliang LIU ; Na CHEN ; Xuan YUAN ; Ying YAO ; Bo ZHANG ; Qiusheng ZHENG
Acta Pharmaceutica Sinica 2012;47(11):1477-82
This study is to investigate the mechanism of human promyelocytic leukemia HL-60 cells proliferation induced by alteronol in vitro. Human promyelocytic leukemia HL-60 cells cultured in vitro were treated with different concentrations of alteronol. Inhibition rate was detected by SRB assay. Cellular morphological changes were observed by Hoechst and AO/EB (acridine orange/ethidium bromide dye) staining. The apoptosis rate was determined by Annexin V-FITC/PI assay. Cell cycle distribution was determined by flow cytometry. Western blotting analysis was carried out to determine the cell cycle related proteins. The proliferation of HL-60 cells treated with alteronol was inhibited in a concentration-dependent manner. Based on cell viability assay, observation on cell morphology and apoptosis rate, it confirmed that alteronol played an obvious role in proliferation inhibition of human promyelocytic leukemia HL-60 cells, but it did not induce apoptosis in human promyelocytic leukemia HL-60 cells in different concentrations groups. Alteronol could effectively inhibit the proliferation of human promyelocytic leukemia HL-60 cells inducing cell cycle arrest at G1 phase, as well as, alteration expression of cell cycle proteins level of CyclinD1 and pRb.
10.Latest Edition and Interpretation of International Standards for Neurological Classification of Spinal Cord InjuryWorksheet
Yiji WANG ; Hongjun ZHOU ; Jianjun LI ; Genlin LIU ; Ying ZHENG ; Chunxia HAO ; Ying ZHANG ; Bo WEI ; Haiqiong KANG ; Xiaolei LU ; Yuan YUAN
Chinese Journal of Rehabilitation Theory and Practice 2015;21(8):879-882
Objective To study the modification of the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) worksheet (2013 version) and the significance for clinical practice. Methods The latest English version of ISNCSCI worksheet- 2013 was compared with the previous version to find the advantages of current version and analyze its significance according to the experience from using the worksheet-2011. Results 11 modifications were found in ISNCSCI-2013, in which some were just discrimination, some were for emphasis, and the others were detailing. Conclusion The ASIA International Standards Committee made prudent modifications according to the practical experience of the ISNCSCI-2011 to make the worksheet more scientific and clear for recording. The modification will be more beneficial to record and determine the evaluation results of neurological examination of spinal cord injury in clinical practice.